Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2021	$ 9,387	$ 123,904,602	$ (60,703,562)	$ 63,210,427
Balance (in shares) at Dec. 31, 2021	28,448,612
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,128,973	0	1,128,973
Issuances of common stock from exercise of stock options	$ 1	7,487	0	7,488
Issuances of common stock from exercise of stock options (in shares)	2,282
Net loss	$ 0	0	(8,473,522)	(8,473,522)
Balance at Mar. 31, 2022	$ 9,388	125,041,062	(69,177,084)	55,873,366
Balance (in shares) at Mar. 31, 2022	28,450,894
Balance at Dec. 31, 2021	$ 9,387	123,904,602	(60,703,562)	$ 63,210,427
Balance (in shares) at Dec. 31, 2021	28,448,612
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from the Sales Agreement, net (in shares)				1,238,491
Balance at Dec. 31, 2022	$ 9,956	145,550,491	(101,558,417)	$ 44,002,030
Balance (in shares) at Dec. 31, 2022	30,170,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,080,319	0	2,080,319
Issuance of common stock from the Sales Agreement, net	$ 183	4,588,339	0	$ 4,588,522
Issuance of common stock from the Sales Agreement, net (in shares)	553,293			553,293
Net loss	$ 0	0	(9,659,918)	$ (9,659,918)
Balance at Mar. 31, 2023	$ 10,139	$ 152,219,149	$ (111,218,335)	$ 41,010,953
Balance (in shares) at Mar. 31, 2023	30,723,610